Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transcatheter hepatic artery embolization for symptomatic hepatic focal nodular hyperplasia
ChiCTR2100048590Phase 3Not yet recruiting
- Sponsor
- The First Medical Center of Chinese PLA General Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bleomycin in focal nodular hyperplasia (FNH) (2 arms), sponsored by The First Medical Center of Chinese PLA General Hospital. Primary endpoint: Disease control rate. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
bleomycin
03
Conditions
focal nodular hyperplasia (FNH)
Beyond the preview
Go deeper on ChiCTR2100048590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048590.